“2015-2019 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation - Review of the POC coagulation market segment, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for coagulation procedures by market segment: - Physician Offices/Group Practices     - Emergency Rooms        - Operating/Recovery Suites       - ICUs/CCUs  - Cancer Clinics         - Ambulatory Care Centers         - Surgery Centers  - Nursing Homes - Birth Centers Sales and Market Share Analysis - Sales and market shares of major reagent and instrument suppliers. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor... Research Beam Model: Research Beam Product ID: 322014 0 USD New
2015-2019 New Frontiers in the Point-of-Care/POC Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape
 
 

2015-2019 New Frontiers in the Point-of-Care/POC Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • Category : Diagnostic and Biotech
  • Published On : August   2015
  • Pages : 450
  • Publisher : VPGMarketResearch.com
 
 
 

2015-2019 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.


Rationale


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.


Market Segmentation


- Review of the POC coagulation market segment, including their dynamics, trends, structure, size, growth and major suppliers.


- Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:



- Physician Offices/Group Practices    

- Emergency Rooms       

- Operating/Recovery Suites      

- ICUs/CCUs 

- Cancer Clinics        

- Ambulatory Care Centers        

- Surgery Centers 

- Nursing Homes

- Birth Centers


Sales and Market Share Analysis


- Sales and market shares of major reagent and instrument suppliers.


Coagulation Tests


Activated Clotting Time (ACT) (1), Activated Protein C Resistance,

Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,

D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,

Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,

Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,

Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,

Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,

Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,

Von Willebrand's Factor Fav/Ag, and others.


Technology Review


- Emerging technologies and their applications for POC testing.


- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.


Strategic Recommendations


- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.


- Design criteria for POC testing products.


- Alternative business expansion strategies.


- Potential market entry barriers and risks.


Competitive Assessments


- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - ADI/American Diagnostica

   - Alere/Biosite/Inverness

   - Axis-Shield

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Bio/Data

   - Chrono-Log

   - Corgenix

   - Diagnostica Stago/Trinity Biotech

   - Grifols

   - Helena Laboratories

   - Hyphen BioMed

   - Instrumentation Laboratory

   - International Technidyne/Nexus DX

   - Roche

   - Siemens

   - Sienco

   - Sysmex

   - ThermoFisher

   - Zycare/Alere


Methodology


This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.


Contains 450 pages and 53 tables

../toc/TOCLOT%20NewFrontiersinPointofCarePOCCoagulationTesting.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT